SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022892
Filing Date
2022-08-15
Accepted
2022-08-15 16:18:52
Documents
53
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 749237
2 ex31-1.htm EX-31.1 18966
3 ex31-2.htm EX-31.2 18961
4 ex32-1.htm EX-32.1 10184
5 ex32-2.htm EX-32.2 10182
  Complete submission text file 0001493152-22-022892.txt   3593167

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sonn-20220630.xsd EX-101.SCH 30163
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sonn-20220630_cal.xml EX-101.CAL 41057
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sonn-20220630_def.xml EX-101.DEF 115253
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sonn-20220630_lab.xml EX-101.LAB 251436
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sonn-20220630_pre.xml EX-101.PRE 196301
47 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 478008
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35570 | Film No.: 221165873
SIC: 2834 Pharmaceutical Preparations